ID   KCC1D_HUMAN             Reviewed;         385 AA.
AC   Q8IU85; B0YIY0; Q9HD31;
DT   07-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   12-OCT-2022, entry version 178.
DE   RecName: Full=Calcium/calmodulin-dependent protein kinase type 1D;
DE            EC=2.7.11.17;
DE   AltName: Full=CaM kinase I delta;
DE            Short=CaM kinase ID;
DE            Short=CaM-KI delta;
DE            Short=CaMKI delta;
DE            Short=CaMKID;
DE   AltName: Full=CaMKI-like protein kinase;
DE            Short=CKLiK;
GN   Name=CAMK1D; Synonyms=CAMKID;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION IN PHOSPHORYLATION OF CREM
RP   AND ACTIVATION OF CREB1, ACTIVITY REGULATION, TISSUE SPECIFICITY, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=11050006;
RA   Verploegen S., Lammers J.-W.L., Koenderman L., Coffer P.J.;
RT   "Identification and characterization of CKLiK, a novel granulocyte
RT   Ca++/calmodulin-dependent protein kinase.";
RL   Blood 96:3215-3223(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CATALYTIC ACTIVITY, ACTIVITY
RP   REGULATION, PHOSPHORYLATION AT THR-180, PHOSPHORYLATION BY CAMKK1 AND
RP   CAMKK2, MUTAGENESIS OF THR-180, AND TISSUE SPECIFICITY.
RX   PubMed=12935886; DOI=10.1016/s0014-5793(03)00817-2;
RA   Ishikawa Y., Tokumitsu H., Inuzuka H., Murata-Hori M., Hosoya H.,
RA   Kobayashi R.;
RT   "Identification and characterization of novel components of a
RT   Ca2+/calmodulin-dependent protein kinase cascade in HeLa cells.";
RL   FEBS Lett. 550:57-63(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=15840691; DOI=10.1182/blood-2004-09-3755;
RA   Verploegen S., Ulfman L., van Deutekom H.W., van Aalst C., Honing H.,
RA   Lammers J.W., Koenderman L., Coffer P.J.;
RT   "Characterization of the role of CaMKI-like kinase (CKLiK) in human
RT   granulocyte function.";
RL   Blood 106:1076-1083(2005).
RN   [8]
RP   FUNCTION IN CREB1 ACTIVATION, SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE,
RP   INDUCTION BY KCL, AND MUTAGENESIS OF LYS-52 AND THR-180.
RX   PubMed=16324104; DOI=10.1111/j.1460-9568.2005.04463.x;
RA   Sakagami H., Kamata A., Nishimura H., Kasahara J., Owada Y., Takeuchi Y.,
RA   Watanabe M., Fukunaga K., Kondo H.;
RT   "Prominent expression and activity-dependent nuclear translocation of
RT   Ca2+/calmodulin-dependent protein kinase Idelta in hippocampal neurons.";
RL   Eur. J. Neurosci. 22:2697-2707(2005).
RN   [9]
RP   FUNCTION IN DENDRITIC GROWTH, AND DEVELOPMENTAL STAGE.
RX   PubMed=17056143; DOI=10.1016/j.neures.2006.09.013;
RA   Kamata A., Sakagami H., Tokumitsu H., Owada Y., Fukunaga K., Kondo H.;
RT   "Spatiotemporal expression of four isoforms of Ca2+/calmodulin-dependent
RT   protein kinase I in brain and its possible roles in hippocampal dendritic
RT   growth.";
RL   Neurosci. Res. 57:86-97(2007).
RN   [10]
RP   REVIEW ON FUNCTION IN NEURONAL PLASTICITY.
RX   PubMed=18817731; DOI=10.1016/j.neuron.2008.08.021;
RA   Wayman G.A., Lee Y.S., Tokumitsu H., Silva A.J., Silva A., Soderling T.R.;
RT   "Calmodulin-kinases: modulators of neuronal development and plasticity.";
RL   Neuron 59:914-931(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-122 AND THR-180, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-113, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 1-333 IN COMPLEX WITH INHIBITOR.
RA   Debreczeni J.E., Rellos P., Fedorov O., Niesen F.H., Bhatia C.,
RA   Shrestha L., Salah E., Smee C., Colebrook S., Berridge G., Gileadi O.,
RA   Bunkoczi G., Ugochukwu E., Pike A.C.W., Von Delft F., Knapp S.,
RA   Sundstrom M., Weigelt J., Arrowsmith C.H., Edwards A.;
RT   "Crystal structure of human calmodulin-dependent protein kinase 1D.";
RL   Submitted (DEC-2006) to the PDB data bank.
RN   [15]
RP   VARIANT [LARGE SCALE ANALYSIS] MET-66.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Calcium/calmodulin-dependent protein kinase that operates in
CC       the calcium-triggered CaMKK-CaMK1 signaling cascade and, upon calcium
CC       influx, activates CREB-dependent gene transcription, regulates calcium-
CC       mediated granulocyte function and respiratory burst and promotes basal
CC       dendritic growth of hippocampal neurons. In neutrophil cells, required
CC       for cytokine-induced proliferative responses and activation of the
CC       respiratory burst. Activates the transcription factor CREB1 in
CC       hippocampal neuron nuclei. May play a role in apoptosis of
CC       erythroleukemia cells. In vitro, phosphorylates transcription factor
CC       CREM isoform Beta. {ECO:0000269|PubMed:11050006,
CC       ECO:0000269|PubMed:15840691, ECO:0000269|PubMed:16324104,
CC       ECO:0000269|PubMed:17056143}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.17;
CC         Evidence={ECO:0000269|PubMed:12935886};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.17; Evidence={ECO:0000269|PubMed:12935886};
CC   -!- ACTIVITY REGULATION: Activated by Ca(2+)/calmodulin. Binding of
CC       calmodulin results in conformational change that relieves intrasteric
CC       autoinhibition and allows phosphorylation of Thr-180 within the
CC       activation loop by CaMKK1 or CaMKK2. Phosphorylation of Thr-180 results
CC       in several fold increase in total activity. Unlike CaMK4, may be unable
CC       to exhibit autonomous activity after Ca(2+)/calmodulin activation.
CC       {ECO:0000269|PubMed:11050006, ECO:0000269|PubMed:12935886}.
CC   -!- INTERACTION:
CC       Q8IU85; Q14012: CAMK1; NbExp=2; IntAct=EBI-3911453, EBI-6380130;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}. Nucleus {ECO:0000305}.
CC       Note=Predominantly cytoplasmic. Nuclear localization increases upon
CC       activation by KCl treatment in hippocampal neurons.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8IU85-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IU85-2; Sequence=VSP_012135;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highly and mostly expressed in
CC       polymorphonuclear leukocytes (neutrophilic and eosinophilic
CC       granulocytes) while little or no expression is observed in monocytes
CC       and lymphocytes. {ECO:0000269|PubMed:11050006,
CC       ECO:0000269|PubMed:12935886, ECO:0000269|PubMed:15840691}.
CC   -!- DEVELOPMENTAL STAGE: Expressed during hippocampal formation with high
CC       expression in the pyramidal cell layers. {ECO:0000269|PubMed:16324104,
CC       ECO:0000269|PubMed:17056143}.
CC   -!- INDUCTION: Expression increases upon treatment of EC cells with DMSO
CC       and retinoic acid. Induced by KCL in PC12 cells.
CC       {ECO:0000269|PubMed:16324104}.
CC   -!- DOMAIN: The autoinhibitory domain overlaps with the calmodulin binding
CC       region and interacts in the inactive folded state with the catalytic
CC       domain as a pseudosubstrate. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. CaMK subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF286366; AAG00534.1; -; mRNA.
DR   EMBL; AB081726; BAC19846.1; -; mRNA.
DR   EMBL; EF444962; ACA05959.1; -; Genomic_DNA.
DR   EMBL; AL391314; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL512284; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL512783; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL731559; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471072; EAW86314.1; -; Genomic_DNA.
DR   EMBL; BC035745; AAH35745.1; -; mRNA.
DR   CCDS; CCDS7091.1; -. [Q8IU85-1]
DR   CCDS; CCDS7092.1; -. [Q8IU85-2]
DR   RefSeq; NP_065130.1; NM_020397.3. [Q8IU85-2]
DR   RefSeq; NP_705718.1; NM_153498.3. [Q8IU85-1]
DR   PDB; 2JC6; X-ray; 2.30 A; A/C=1-333.
DR   PDB; 6QP5; X-ray; 1.90 A; A=10-329.
DR   PDB; 6T28; X-ray; 1.55 A; AAA=1-385.
DR   PDB; 6T29; X-ray; 1.48 A; AAA=1-385.
DR   PDB; 6T6F; X-ray; 1.97 A; A/B=10-329.
DR   PDBsum; 2JC6; -.
DR   PDBsum; 6QP5; -.
DR   PDBsum; 6T28; -.
DR   PDBsum; 6T29; -.
DR   PDBsum; 6T6F; -.
DR   AlphaFoldDB; Q8IU85; -.
DR   SMR; Q8IU85; -.
DR   BioGRID; 121382; 50.
DR   IntAct; Q8IU85; 22.
DR   STRING; 9606.ENSP00000478874; -.
DR   BindingDB; Q8IU85; -.
DR   ChEMBL; CHEMBL5073; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugBank; DB08454; N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE.
DR   DrugCentral; Q8IU85; -.
DR   GuidetoPHARMACOLOGY; 1953; -.
DR   GlyGen; Q8IU85; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q8IU85; -.
DR   PhosphoSitePlus; Q8IU85; -.
DR   BioMuta; CAMK1D; -.
DR   DMDM; 56404610; -.
DR   EPD; Q8IU85; -.
DR   jPOST; Q8IU85; -.
DR   MassIVE; Q8IU85; -.
DR   MaxQB; Q8IU85; -.
DR   PaxDb; Q8IU85; -.
DR   PeptideAtlas; Q8IU85; -.
DR   PRIDE; Q8IU85; -.
DR   ProteomicsDB; 70522; -. [Q8IU85-1]
DR   ProteomicsDB; 70523; -. [Q8IU85-2]
DR   Antibodypedia; 1550; 446 antibodies from 36 providers.
DR   DNASU; 57118; -.
DR   Ensembl; ENST00000378845.5; ENSP00000368122.1; ENSG00000183049.14. [Q8IU85-2]
DR   Ensembl; ENST00000619168.5; ENSP00000478874.1; ENSG00000183049.14. [Q8IU85-1]
DR   GeneID; 57118; -.
DR   KEGG; hsa:57118; -.
DR   MANE-Select; ENST00000619168.5; ENSP00000478874.1; NM_153498.4; NP_705718.1.
DR   UCSC; uc001iln.4; human. [Q8IU85-1]
DR   CTD; 57118; -.
DR   DisGeNET; 57118; -.
DR   GeneCards; CAMK1D; -.
DR   HGNC; HGNC:19341; CAMK1D.
DR   HPA; ENSG00000183049; Tissue enhanced (retina).
DR   MIM; 607957; gene.
DR   neXtProt; NX_Q8IU85; -.
DR   OpenTargets; ENSG00000183049; -.
DR   PharmGKB; PA134992438; -.
DR   VEuPathDB; HostDB:ENSG00000183049; -.
DR   eggNOG; KOG0032; Eukaryota.
DR   GeneTree; ENSGT00940000156776; -.
DR   InParanoid; Q8IU85; -.
DR   OMA; ADCPEGK; -.
DR   OrthoDB; 25795at2759; -.
DR   PhylomeDB; Q8IU85; -.
DR   TreeFam; TF314166; -.
DR   BRENDA; 2.7.11.17; 2681.
DR   PathwayCommons; Q8IU85; -.
DR   SignaLink; Q8IU85; -.
DR   SIGNOR; Q8IU85; -.
DR   BioGRID-ORCS; 57118; 8 hits in 1108 CRISPR screens.
DR   ChiTaRS; CAMK1D; human.
DR   EvolutionaryTrace; Q8IU85; -.
DR   GenomeRNAi; 57118; -.
DR   Pharos; Q8IU85; Tchem.
DR   PRO; PR:Q8IU85; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q8IU85; protein.
DR   Bgee; ENSG00000183049; Expressed in middle temporal gyrus and 181 other tissues.
DR   ExpressionAtlas; Q8IU85; baseline and differential.
DR   Genevisible; Q8IU85; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IBA:GO_Central.
DR   GO; GO:0004683; F:calmodulin-dependent protein kinase activity; IDA:MGI.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0007399; P:nervous system development; IEA:UniProtKB-KW.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0032793; P:positive regulation of CREB transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB.
DR   GO; GO:0090023; P:positive regulation of neutrophil chemotaxis; ISS:UniProtKB.
DR   GO; GO:0050766; P:positive regulation of phagocytosis; IMP:UniProtKB.
DR   GO; GO:0060267; P:positive regulation of respiratory burst; IMP:UniProtKB.
DR   GO; GO:0050773; P:regulation of dendrite development; IMP:UniProtKB.
DR   GO; GO:0071622; P:regulation of granulocyte chemotaxis; IMP:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Allosteric enzyme; Alternative splicing; ATP-binding;
KW   Calcium; Calmodulin-binding; Cytoplasm; Inflammatory response;
KW   Isopeptide bond; Kinase; Neurogenesis; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase; Ubl conjugation.
FT   CHAIN           1..385
FT                   /note="Calcium/calmodulin-dependent protein kinase type 1D"
FT                   /id="PRO_0000086082"
FT   DOMAIN          23..279
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          279..319
FT                   /note="Autoinhibitory domain"
FT                   /evidence="ECO:0000250"
FT   REGION          299..320
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          360..385
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           318..324
FT                   /note="Nuclear export signal"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        144
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         29..37
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         52
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         122
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         180
FT                   /note="Phosphothreonine; by CaMKK1 and CaMKK2"
FT                   /evidence="ECO:0000269|PubMed:12935886,
FT                   ECO:0007744|PubMed:18669648"
FT   CROSSLNK        113
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25218447"
FT   VAR_SEQ         348..385
FT                   /note="LAPSTLCSFISSSSGVSGVGAERRPRPTTVTAVHSGSK -> AYVAKPESLS
FT                   (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11050006"
FT                   /id="VSP_012135"
FT   VARIANT         66
FT                   /note="I -> M (in dbSNP:rs34194224)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040599"
FT   MUTAGEN         52
FT                   /note="K->A: Catalytically inactive form."
FT                   /evidence="ECO:0000269|PubMed:16324104"
FT   MUTAGEN         180
FT                   /note="T->A: Loss of ionomycin-induced activation."
FT                   /evidence="ECO:0000269|PubMed:12935886,
FT                   ECO:0000269|PubMed:16324104"
FT   STRAND          13..15
FT                   /evidence="ECO:0007829|PDB:2JC6"
FT   HELIX           19..21
FT                   /evidence="ECO:0007829|PDB:6QP5"
FT   STRAND          23..31
FT                   /evidence="ECO:0007829|PDB:6QP5"
FT   STRAND          36..42
FT                   /evidence="ECO:0007829|PDB:6QP5"
FT   TURN            43..45
FT                   /evidence="ECO:0007829|PDB:6QP5"
FT   STRAND          48..55
FT                   /evidence="ECO:0007829|PDB:6QP5"
FT   HELIX           56..59
FT                   /evidence="ECO:0007829|PDB:6T6F"
FT   HELIX           66..73
FT                   /evidence="ECO:0007829|PDB:6QP5"
FT   STRAND          84..89
FT                   /evidence="ECO:0007829|PDB:6QP5"
FT   STRAND          91..98
FT                   /evidence="ECO:0007829|PDB:6QP5"
FT   STRAND          103..105
FT                   /evidence="ECO:0007829|PDB:6T6F"
FT   HELIX           106..113
FT                   /evidence="ECO:0007829|PDB:6QP5"
FT   HELIX           118..137
FT                   /evidence="ECO:0007829|PDB:6QP5"
FT   HELIX           147..149
FT                   /evidence="ECO:0007829|PDB:6QP5"
FT   STRAND          150..156
FT                   /evidence="ECO:0007829|PDB:6QP5"
FT   STRAND          161..163
FT                   /evidence="ECO:0007829|PDB:6QP5"
FT   HELIX           190..193
FT                   /evidence="ECO:0007829|PDB:6QP5"
FT   HELIX           201..216
FT                   /evidence="ECO:0007829|PDB:6QP5"
FT   HELIX           226..234
FT                   /evidence="ECO:0007829|PDB:6QP5"
FT   TURN            242..247
FT                   /evidence="ECO:0007829|PDB:6QP5"
FT   HELIX           250..259
FT                   /evidence="ECO:0007829|PDB:6QP5"
FT   TURN            264..266
FT                   /evidence="ECO:0007829|PDB:6QP5"
FT   HELIX           270..275
FT                   /evidence="ECO:0007829|PDB:6QP5"
FT   HELIX           277..280
FT                   /evidence="ECO:0007829|PDB:6QP5"
FT   HELIX           290..300
FT                   /evidence="ECO:0007829|PDB:6QP5"
FT   HELIX           305..311
FT                   /evidence="ECO:0007829|PDB:2JC6"
FT   TURN            323..327
FT                   /evidence="ECO:0007829|PDB:6T6F"
SQ   SEQUENCE   385 AA;  42914 MW;  717467D019E30FC9 CRC64;
     MARENGESSS SWKKQAEDIK KIFEFKETLG TGAFSEVVLA EEKATGKLFA VKCIPKKALK
     GKESSIENEI AVLRKIKHEN IVALEDIYES PNHLYLVMQL VSGGELFDRI VEKGFYTEKD
     ASTLIRQVLD AVYYLHRMGI VHRDLKPENL LYYSQDEESK IMISDFGLSK MEGKGDVMST
     ACGTPGYVAP EVLAQKPYSK AVDCWSIGVI AYILLCGYPP FYDENDSKLF EQILKAEYEF
     DSPYWDDISD SAKDFIRNLM EKDPNKRYTC EQAARHPWIA GDTALNKNIH ESVSAQIRKN
     FAKSKWRQAF NATAVVRHMR KLHLGSSLDS SNASVSSSLS LASQKDCLAP STLCSFISSS
     SGVSGVGAER RPRPTTVTAV HSGSK
//
